{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Except for curcumin, which equally inhibited JcR2a and the flunarizine resistant Jc1 variant JcR2a-Flun-R, all other compounds were much less active against JcR2a-Flun-R (change in IC50 18 to 275-fold). \n* Passaging of an HCV genotype 2a virus (Jc1) in the presence of flunarizine yielded a combination of three mutations that map to the E1 and E2 proteins and which confer a ca. 50-fold resistance to flunarizine"}
{"final_json": [{"molecule_name": "curcumin", "protein_target_name": null, "binding_metric": "IC50", "value": "18 to 275-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "flunarizine", "protein_target_name": "E1 and E2 proteins", "binding_metric": null, "value": "50-fold", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In fact, four residues within this region and which are conserved among sensitive GT2a strains (M/V290, W299, V301, P310) and where resistant GT2b strains encode a conserved alternative reside (A290, N299, T301, Q310) cause and 8-fold, 6-fold or 27-fold shift of the IC50 of flunarizine, chlorcyclizine and p-methoxy-flunarizine, respectively."}
{"final_json": [{"molecule_name": "flunarizine", "protein_target_name": null, "binding_metric": "IC50", "value": "8-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "chlorcyclizine", "protein_target_name": null, "binding_metric": "IC50", "value": "6-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": "p-methoxy-flunarizine", "protein_target_name": null, "binding_metric": "IC50", "value": "27-fold", "unit": null, "is_logarithmic": false}]}
